Adaptation of Evidence-based Interventions and De-Implementation of Ineffective Programs

Preview:

Citation preview

Emerging Topics in Implementation Science

Adaptation of Evidence-based Interventions and

De-Implementation of Ineffective Programs

Wynne E. Norton, PhD

Program Officer, National Cancer Institute

November 14, 2017

2

Disclosure

I have no financial relationships to disclose.

Opinions are mine, not official positions of the National Cancer

Institute, the National Institutes of Health, or the U.S. federal

government.

3

Overview

Fidelity vs. adaptation of evidence-based interventions

Definitions, concepts, models, future research

De-implementation of ineffective programs

Definitions, NIH portfolio analysis, future research

Questions, comments

4

Fidelity of Evidence-based Interventions

“Extent to which the intervention was delivered as planned. It

represents the quality and integrity of the intervention as conceived by

developers.” (Brownson et al., 2012)

Why is fidelity important?

Maintains integrity of intervention.

Increases probability that intervention will have impact.

5

Fidelity Measurements

How do we know if fidelity is maintained?

Fidelity measures

Differentiate between intervention not working (ineffective) and

intervention not being implemented appropriately.

Self-report (e.g., clinicians), individual/patient reports,

observation, audio/video recordings.

6

Adaptation of Evidence-based Interventions

“Planned or purposeful changes to the design or delivery of an

intervention” (Stirman et al., 2013).

Interventions likely need to be adapted to fit context:

Target population, delivery setting, urban/rural, community, etc.

“Intervention-implementation fit”

How do you adapt the evidence-based intervention to increase “fit”

without sacrificing potential impact on targeted outcomes?

7

Intervention Elements: Core vs. Peripheral

Core Elements

Elements of the intervention that cannot be deleted or dropped

If elements are adapted, should be a planned and purposeful

process with input from end users

Peripheral Elements

Elements of the intervention that can be deleted or dropped, as

needed (e.g., limited resources, time constraints)

8

Intervention Elements: Adaptation

What elements can be adapted…and by how much?

Elements that can be modified:

Names, pictures, places, quotes, nomenclature, incentives for

participation, timeline of delivery

Elements that should not be modified:

Health topic, entire sections of program, core elements, guiding model,

theory, or framework, targeted health behavior

R. Brownson. Red light, yellow light, green light adaptations.

9

Intervention Elements: Guidance for Adaptation Process

How do I make modifications to intervention elements?

Purposeful

Planned

Informed by guiding theory, framework, or model of behavior change

underlying evidence-based intervention

Stakeholder input

Pilot test, revise

Monitor

10

Toward a Science of Adaptation

How can we advance our scientific understanding of intervention

adaptation?

(1) Frameworks and models

Classification of adaptations (Stirman et al., 2013)

ADAPT-ITT (Wingood & DiClemente, 2008)

Dynamic Adaptation Process (Aarons et al., 2012)

Adaptome (Chambers & Norton, 2015)

(2) Research questions and opportunities

11

Sources of Intervention Adaptation

Stirman et al., 2013

12

Adaptation Frameworks & Models: ADAPT-ITT

Wingood & DiClemente, 2008

13

ADAPT-ITT Model: Example

Wingood & DiClemente, 2008

14

Dynamic Adaptation Process

Aarons et al., 2012

15

Sources of Intervention Adaptation

Chambers & Norton, 2015

16Adaptome, Chambers & Norton, 2015

17

Adaptation Research Questions and Opportunities

Assessment of intervention adaptation in vivo in local settings.

Standardized reporting of adaptation processes.

At what point does an existing evidence-based intervention become a

new intervention…and what does that mean in terms of ‘evidence’?

When and what type of adaptations lead to negative outcomes?

When and what type of adaptations lead to more outcomes (e.g.,

positive deviance)?

18

De-Implementation of Ineffective Programs

Increasing recognition of harms associated with overscreening,

overdiagnosis, and overtreatment (overuse).

Use of ineffective, low-value, or untested practices, programs,

interventions.

Inefficiency, waste, poor use of resources.

19

De-Implementation: Definitions and Terms

Nieven et al. 2015

20

De-Implementation: Definitions and Terms

Disinvestment

Processes of withdrawing (partially or completely) health

resources from any existing health care practices, procedures,

technologies or pharmaceuticals that are deemed to deliver little or

no health gain for their cost, and are thus not efficient health

resource allocations.

De-adoption

Discontinuation of a clinical practice after it was previously

adopted.

Editor’s Note, Implementation Science, 2014; Elshaug et al., 2007; Prasad & Ioannidis, 2014

21

De-Implementation: Definitions and Terms

De-prescribe

Process of tapering, stopping, discontinuing, or withdrawing drugs,

with the goal of managing polypharmacy and improving outcomes.

De-implementation “We regard de-implementation broadly as ‘stopping practices that are not

evidence-based.’”

Reduce (frequency and/or intensity) or stop the delivery of ineffective,

unproven, harmful, overused, inappropriate, and/or low-value health

services and practices provided to patients by healthcare practitioners

and systems.

Thompson & Farrell, 2013; Rogers, 2003; Prasad & Cifu, 2015; Norton et al., in press

22

Current State of De-Implementation Research

Terminology, definitions

Conceptual papers

Specialized scientific conferences (e.g., Preventing Overdiagnosis)

Professional society initiatives (e.g., ChoosingWisely campaign)

Identification of possible strategies to reduce low-value care

Funded research studies…?

Norton et al., in press; Colla et al., 2016; Niven et al., 2015

23

Systematic Review of NIH-funded Studies

Identify, describe, and characterize funded research grants on de-

implementation

Snapshot of state-of-the-science

Portfolio analysis across 27 NIH Institutes and Centers and AHRQ,

2000-2017

Searched grants database, 11 key terms, 3 specific funding

announcements

Assess eligibility, develop and apply codebook

24

25

Results

N = 20 funded research grants

15 NIH funded, 5 AHRQ funded

11 awarded 2015-2016

Example grant titles

Impact of social contagion on physician use of unproven cancer

interventions

Identifying cascades of low-value care and the organizational

practices that prevent them

26

Study Features*

Objectives Understand or characterize factors

influencing de-implementation

14

Develop strategies to facilitate

de-implementation

16

Health Area Cancer 8

Cardiovascular Disease 1

Infectious Diseases 3

Kidney Disease 1

Mental Health 2

Continuum of Care Prevention 2

Screening and/or Detection 5

Diagnosis 3

Treatment 14

*Select results

27*Select results

Study Features*

Health Service/

Practice

Drugs, Medications, or Therapies 15

Preventive, Diagnostic, or Screenings Tests 8

Setting Clinical care 16

Hospital 4

Assisted Living Facility 2

School 1

Design & Methods Experimental 7

Quasi-experimental 5

Observational 7

Mixed Methods 4

Qualitative 3

28

Summary

Relatively few research grants focused on de-implementation.

Additional effort is needed to increase awareness of and interest in

studying de-implementation.

Funding opportunities.

Synthesize and operationalize terms.

Collaborate with ongoing initiatives.

Others?

29

Future Directions

How are implementation and de-implementation similar?

How are they different?

Models, frameworks, theories?

Processes?

Strategies?

Ethical considerations?

30

Closing

Very exciting time to be in the field of implementation research!

Opportunity to advance science and improve practice.

Adaptation and de-implementation are two emerging areas of inquiry

in the field.

31

Questions? Comments?

Wynne E. Norton, PhD

Program Officer, Implementation Science

Division of Cancer Control and Population Sciences

National Cancer Institute

wynne.norton@nih.gov

www.cancer.gov www.cancer.gov/espanol

Recommended